S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00004001 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

770

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: estramustine
DRUG: mitoxantrone
DRUG: prednisone

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]